Skip to main content
Clinical Trials/NCT01603589
NCT01603589
Completed
Not Applicable

Research on Remote End-organ Protection, Clinical Outcome and Quality of Life With Implementation of the Novel Minimal Extracorporeal Circulation Circuit in Open Heart Surgery

AHEPA University Hospital1 site in 1 country150 target enrollmentJanuary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Bypass
Sponsor
AHEPA University Hospital
Enrollment
150
Locations
1
Primary Endpoint
Remote end-organ perfusion and function (brain, lungs, liver, kidneys, stomach, intestine) intraoperatively and postoperatively during hospital stay
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to assess the effect of minimal (MiECC) versus conventional (CECC) extracorporeal circulation on perfusion characteristics and remote end-organ protection (lungs, brain, kidneys, liver, stomach, intestine), after elective coronary bypass grafting (CABG).

Detailed Description

The aim of this study is to investigate whether coronary surgery with minimal Invasive Extracorporeal Circulation (MiECC) offers advantage over conventional CPB (CECC). In order to draw an evidence-based conclusion, the investigators aim to evaluate perfusion characteristics during coronary surgery with MECC and associated remote end-organ function. Improved end-organ protection translates into improved clinical outcome which greatly affects quality of life. This is the first study in the literature adequately powered to analyse organ pathophysiology during surgery with MECC and at the same time correlating common clinical variables with a detailed quality of life evaluation. Superiority of MECC could provide firm evidence towards widespread use of MECC in coronary surgery as standard of care.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
December 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kyriakos Anastasiadis

Professor

AHEPA University Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients scheduled for elective coronary artery bypass grafting

Exclusion Criteria

  • history of psychiatric disorder
  • inability to undergo neuropsychological assessment
  • history of transient ischemic attack or stroke
  • carotid artery stenosis \> 60% assessed by duplex ultrasonography

Outcomes

Primary Outcomes

Remote end-organ perfusion and function (brain, lungs, liver, kidneys, stomach, intestine) intraoperatively and postoperatively during hospital stay

Time Frame: 30 days

Remote end-organ perfusion and function at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

Secondary Outcomes

  • Development of new postoperative atrial fibrillation.(30 days)
  • Health-related quality of life(6 months postoperatively)
  • Length of ICU stay(30 days)
  • Neurocognitive function(6 months postoperatively)
  • Postoperative major adverse cardiac and cerebrovascular events (MACCE) that comprise: myocardial infarction, low cardiac output syndrome, stroke, renal failure.(30 days)
  • Duration of mechanical ventilation(30 days)

Study Sites (1)

Loading locations...

Similar Trials